Background Italy is a high-risk area for multiple sclerosis with 110,000 prevalent cases estimated at January 2016 and 3400 annual incident cases. To study multiple sclerosis epidemiology, it is preferable to use population-based studies, e.g., with a registry. A valid alternative to obtain data on entire population is from administrative sources. Objective To estimate the incidence of multiple sclerosis in Tuscany using a case-finding algorithm based on administrative data. Methods In a previous study, we calculated the prevalence in Tuscany using a validated case-finding algorithm based on administrative data. Incident cases were identified as a subset of prevalent cases among those patients not traced in the years before the analysis period, and the date of the first multiple sclerosis-related claim was considered the incidence date of multiple sclerosis diagnosis. We examined the period 2011-2015.
Introduction
Multiple sclerosis (MS) affects 2.3 million people worldwide, with a median prevalence and incidence of 35 and 4 cases per 100,000, respectively [1] . A recent review reported a median estimated prevalence of 112.0 (with a range of 5.2-335) and a median estimated incidence of 5.2 (range 0.5-20.6) per 100,000 [2] , but the distribution is very heterogeneous [3] . Italy is a high-risk zone with more than 109,000 estimated prevalent patients in 2015 [4] and 3400 incident cases per year [5] .
Regarding incidence, latest published papers report 5.5 cases per 100,000 in Padua for the period 2000-2009 [6] , 6.7 cases in Genoa for the period 1998-2007 [7] , and 9.7 cases per 100,000 in Sardinia for the period 2003-2007 [8] .
To monitor disease epidemiology, comorbidities, and care pathways, but also to describe the disease burden and to plan its prevention, treatment, and management strategies and resource allocation, population-based studies are preferable [9, 10] . For these reasons, and also for the surveillance and the long-term monitoring of people with MS and other chronic diseases, there are disease-specific clinical registries. In the past, many MS centers in Italy used iMed, an electronic clinical database, constituting the Multiple Sclerosis Database Network [11, 12] . A national population registry has been founded in 2015 and it will represent, in the next future, a valid tool to study MS epidemiology. Furthermore, there are two regional MS registries, in Tuscany and in Liguria, both promoted by the Italian Multiple Sclerosis Foundation (FISM).
In addition to clinical registries, another valid data source for population-based prevalence study of chronic diseases is the administrative one [9, [13] [14] [15] . Administrative sources provide data in a cost-effective, continuative, and standardized way, and they cover the entire resident population enrolled in publicly funded health systems, such as the Italian system [14] , with the possibility to link to individual consumption of resources. However, administrative data may have some problems with the quality; it does not include specific clinical information, and some population subgroups, nor those services uncovered by the National Health Service (NHS). To reduce these problems, it will be desirable to merge clinical registries and administrative data to obtain a complete view of the disease, collecting both clinical and health care information [13] .
In Italy, NHS is organized in a national, regional, and local level. Administrative data, such as inpatient and outpatient care, and drug dispensations, is routinely and uniformly collected by Italian local health authorities (LHAs). Data is sent in an anonymous form to the national level, without the unique personal identification code; so, record linkage can be performed only in the local and regional levels. This local data forms the Italian administrative databases [15] .
In a previous study, in the Tuscany region, we created and validated a case-finding algorithm, based on administrative data, to identify MS patients and to calculate the prevalence as at 2011 [16] . The algorithm had a sensitivity of 98% and a specificity of 99.99%. We identified 6890 prevalent cases as at 31/12/2011, with a resulting rate of 187.9 cases per 100,000, 248.3 per 100,000 in females and 122.3 per 100,000 in males [16] .
Also in other Italian regions, administrative data have been used to calculate MS prevalence, as in Lazio with 131 cases per 100,000 as at 2011 [17] , in Apulia with 183 cases as at 2012, in Veneto with 170-180 cases as at 2015, in Sicily with 110 cases as at 2010, and Sardinia with 360 cases as at 2016 [5] .
In literature, there are several paper reporting the use of administrative data to estimate incidence, both for MS [18, 19] and for other chronic diseases, as type 1 diabetes [20, 21] , rheumatoid arthritis [22] , amyotrophic lateral sclerosis [23] , epilepsy [24] , and cancers [25] .
In this study, our aim is to identify MS incident cases in Tuscany, using administrative data, from 2011 to 2015.
Materials and methods

Data sources
We obtained data from the Tuscan health administrative databases in observance of the privacy law. The Tuscany region is divided into 12 LHAs that provide health care for their residents. Population in Tuscany was quite stable in the period 2011-2015: it was composed by 3,749,813 inhabitants as at 1/ 1/2011, 3,667,780 in 2012, 3,692,828 in 2013, 3,750,511 in 2014, and 3,752,654 in 2015 [26] .
Our data sources were hospital discharge records, drug dispensing records, and disease-specific payment exemptions from co-payment to health care (see Table 1 for details).
We made a record linkage using the unique personal identification code.
Case ascertainment
We created a case-finding algorithm in which we linked hospital discharge records, drug dispensation records, and disease-specific exemptions up to the end of each analyzed year.
The cohort was composed by all inhabitants alive at the prevalence day who met at least one of the following criteria: (A) at least one hospital discharge record (SDO) with MS as main diagnosis, (B) the issuing of a payment exemption Coded using ICD9CM 340
Inhabitant registry
With demographic information to know if inhabitants were alive at the prevalence day (SEA) for MS, and (C) at least two drug prescriptions (FED+ SPF) with different dates for at least one of the eight drugs that are specific for MS (see Table 2 ). Incident cases were identified as a subset of prevalent cases among those patients not traced in the previous years.
The first record in the health administrative databases was considered as the date of MS diagnosis. From this cohort of incident cases, we selected patients with an age ≤ 60 years, who lived in Tuscany at the date of MS diagnosis and who were in the beneficiaries of the regional health system registry from at least 10 years (or patients born in Tuscany if were < 10 years old), to exclude capturing a patient coming from another region as an incident case.
Then, we calculated crude and standardized (for Tuscan population as at 01/01/2015) incidence for the years 2011-2015 and the confidence interval at 95%.
Results
We identified 1147 incident cases (380 males and 767 females) from 2011 to 2015, of which 210 in 2011, 216 in 2012, 224 in 2013, 250 in 2014, and 247 in 2015. The total crude incidence obtained ranged from 5.60 per 100,000 in 2011 to 6.58 per 100,000 in 2015 (Table 3 ) with a mean of 6.09 for the entire period.
In females, standardized incidence rate was around two times much high than that in males, with a range from 7.05 in 2011 to 9.08 cases per 100,000 in females and from 3.84 to 4.03 in males (Table 4) . Considering female to male ratio, it ranged from 1.84 to 2.25, with an average of 2.02 for the entire period.
We calculated median age at diagnosis and it was stable for the studied period: 39 at 2011, 41 at 2012, 40.5 at 2013, and 40 at 2014 and 2015.
Analyzing standardized rates by each of the 12 LHAs of residence, we calculated the mean incidence in the period and we observed that the LHAs 8, 3, 11, 10, and 6 had a rate higher than the mean rate of the region, whereas the LHAs 1, 2, and 12 had the lowest rate (Table 5) .
Discussion
The estimate, based on the national average of incidence published by the Italian MS patient society (AISM), indicates an incidence of 1025 new cases of disease in Tuscany in the analyzed period [5] . This estimate does not differ so much from our result of 1147 incident cases. The result obtained from administrative data, corrected by the inclusion of only cases with an age ≤ 60 years, who were in the beneficiaries of the regional health system registry from at least 10 years, could get near to the real data, even if it was only an estimate. Considering sex differences, the incidence was higher in the women, with a female to male ratio of about 2, as published in other countries, for example, 2.26 in Sweden [27] , 2.0 in Norway [28] , 2.19 in the Isle of Man [29] , and 1.9 in Kuwait [30] . Nonetheless, in literature, we found higher ratio, as in South East Wales with 4.3 [31] , in Brittany with 2.95 [32] , and in Canada with 2.6 [33] .
The used method is not an overestimation due to the selection of our cohort. Indeed, our results suggest a high incidence similar to the published rates in other Italian cities, as Padua or Genoa [6, 7] , even though methodological bias due to the use of administrative data. In fact, limits of this study are the quality and accuracy of administrative data and the possibility of tracing only the presumed date of MS diagnosis. Nevertheless, with the improvement of diagnostic criteria, the latency time between onset and diagnosis has greatly decreased in recent years. Regarding the possibility that some patients could have received the diagnosis outside Tuscany, these patients will soon be traced by Tuscan data sources and this delay does not influence the average incidence in 5-year time.
To confirm our results, in a subsequent study, we will validate the algorithm comparing information obtained from administrative sources with the ones from other sources. As the Tuscan register is not yet completed, it is not possible to compare our data with that in the register, and we will use clinical information from MS center databases of Tuscany. Anyhow, we have described an alternative and economic method for estimate incidence rate using administrative data. We have shown that it can be used to estimate MS incidence in a region. We expected that the algorithm will be tested in other Italian regions to compare results.
The monitoring of chronic diseases with cost-effective and routine methods, as administrative data, could be very useful in helping healthcare providers. In fact, the knowledge of the burden of diseases could ameliorate the health strategies for disease management, especially in high-risk zone, as Italy, and for diseases with a very high socio-economic impact, as MS [19, 34] .
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